Sébastien Wälchli

3.6k total citations
92 papers, 2.8k citations indexed

About

Sébastien Wälchli is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Sébastien Wälchli has authored 92 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Immunology, 49 papers in Oncology and 48 papers in Molecular Biology. Recurrent topics in Sébastien Wälchli's work include CAR-T cell therapy research (43 papers), Immunotherapy and Immune Responses (23 papers) and Immune Cell Function and Interaction (17 papers). Sébastien Wälchli is often cited by papers focused on CAR-T cell therapy research (43 papers), Immunotherapy and Immune Responses (23 papers) and Immune Cell Function and Interaction (17 papers). Sébastien Wälchli collaborates with scholars based in Norway, United States and Germany. Sébastien Wälchli's co-authors include Kirsten Sandvig, Else Marit Inderberg, Rob Hooft van Huijsduijnen, Gunnar Kvalheim, Gustav Gaudernack, Sigrid S. Skånland, Pierre Dillard, Hakan Köksal, June H. Myklebust and Rosanna Pescini Gobert and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Neuroscience.

In The Last Decade

Sébastien Wälchli

90 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sébastien Wälchli Norway 33 1.4k 1.0k 847 593 259 92 2.8k
Christina Voelkel‐Johnson United States 34 2.0k 1.4× 539 0.5× 595 0.7× 411 0.7× 300 1.2× 81 2.8k
Chunqing Guo United States 29 1.5k 1.0× 1.2k 1.2× 611 0.7× 242 0.4× 116 0.4× 66 2.9k
Huijie Bian China 32 2.2k 1.6× 882 0.9× 698 0.8× 288 0.5× 311 1.2× 108 3.7k
Russell W. Jenkins United States 28 2.0k 1.4× 1.0k 1.0× 1.2k 1.4× 406 0.7× 96 0.4× 57 3.5k
Thierry Dubois France 32 2.7k 1.9× 373 0.4× 932 1.1× 765 1.3× 286 1.1× 79 3.8k
Tomohiko Fukuda Japan 36 2.3k 1.6× 1.1k 1.0× 469 0.6× 615 1.0× 132 0.5× 87 3.2k
Naoto Yamaguchi Japan 35 2.1k 1.5× 1.1k 1.0× 681 0.8× 876 1.5× 199 0.8× 128 3.9k
Keith S. Hoek Switzerland 29 3.3k 2.3× 932 0.9× 1.5k 1.7× 1.2k 2.0× 170 0.7× 40 4.4k
Laura M. Selfors United States 25 2.0k 1.4× 308 0.3× 874 1.0× 473 0.8× 157 0.6× 43 3.2k
Andrew C.G. Porter United Kingdom 32 2.8k 1.9× 570 0.6× 999 1.2× 471 0.8× 366 1.4× 83 3.6k

Countries citing papers authored by Sébastien Wälchli

Since Specialization
Citations

This map shows the geographic impact of Sébastien Wälchli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sébastien Wälchli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sébastien Wälchli more than expected).

Fields of papers citing papers by Sébastien Wälchli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sébastien Wälchli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sébastien Wälchli. The network helps show where Sébastien Wälchli may publish in the future.

Co-authorship network of co-authors of Sébastien Wälchli

This figure shows the co-authorship network connecting the top 25 collaborators of Sébastien Wälchli. A scholar is included among the top collaborators of Sébastien Wälchli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sébastien Wälchli. Sébastien Wälchli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Huse, Kanutte, Baoyan Bai, Thea Kristin Våtsveen, et al.. (2022). Mechanism of CD79A and CD79B Support for IgM+ B Cell Fitness through B Cell Receptor Surface Expression. The Journal of Immunology. 209(10). 2042–2053. 32 indexed citations
3.
Duarte, Henrique O., et al.. (2022). CAR‐Ts: new perspectives in cancer therapy. FEBS Letters. 596(4). 403–416. 22 indexed citations
4.
Mensali, Nadia, Noemi Antonella Guadagno, Marine Bretou, et al.. (2021). Rab7b regulates dendritic cell migration by linking lysosomes to the actomyosin cytoskeleton. Journal of Cell Science. 134(18). 18 indexed citations
5.
Bai, Baoyan, June H. Myklebust, & Sébastien Wälchli. (2020). Gene Editing in B-Lymphoma Cell Lines Using CRISPR/Cas9 Technology. Methods in molecular biology. 2115. 445–454. 6 indexed citations
6.
Winge-Main, A., Sébastien Wälchli, & Else Marit Inderberg. (2020). T cell receptor therapy against melanoma—Immunotherapy for the future?. Scandinavian Journal of Immunology. 92(4). e12927–e12927. 9 indexed citations
7.
Beiske, Klaus, Yngvild Nuvin Blaker, Harald Holte, et al.. (2019). TIGIT and PD-1 Mark Intratumoral T Cells with Reduced Effector Function in B-cell Non-Hodgkin Lymphoma. Cancer Immunology Research. 7(3). 355–362. 82 indexed citations
8.
Mensali, Nadia, Amalie Grenov, Niladri Bhusan Pati, et al.. (2019). Antigen-delivery through invariant chain (CD74) boosts CD8 and CD4 T cell immunity. OncoImmunology. 8(3). 1558663–1558663. 22 indexed citations
9.
Köksal, Hakan, Pierre Dillard, Sólrún Melkorka Maggadóttir, et al.. (2019). Preclinical development of CD37CAR T-cell therapy for treatment of B-cell lymphoma. Blood Advances. 3(8). 1230–1243. 39 indexed citations
10.
Lampen, Margit H., Hannes Uchtenhagen, Kim Blom, et al.. (2018). Breadth and Dynamics of HLA-A2– and HLA-B7–Restricted CD8+ T Cell Responses against Nonstructural Viral Proteins in Acute Human Tick-Borne Encephalitis Virus Infection. ImmunoHorizons. 2(6). 172–184. 13 indexed citations
11.
Köksal, Hakan, Elisabeth Müller, Else Marit Inderberg, Øyvind S. Bruland, & Sébastien Wälchli. (2018). Treating osteosarcoma with CAR T cells. Scandinavian Journal of Immunology. 89(3). e12741–e12741. 39 indexed citations
12.
Wälchli, Sébastien, Marit Renée Myhre, Nadia Mensali, et al.. (2017). Abstract 3773: Tapping CD4 T cells for cancer immunotherapy. Cancer Research. 77(13_Supplement). 3773–3773. 1 indexed citations
13.
Belnoue, Elodie, Wilma Di Berardino-Besson, Hubert Gaertner, et al.. (2016). Enhancing Antitumor Immune Responses by Optimized Combinations of Cell-penetrating Peptide-based Vaccines and Adjuvants. Molecular Therapy. 24(9). 1675–1685. 33 indexed citations
14.
Kumari, Shraddha, Sébastien Wälchli, Lars-Egil Fallang, et al.. (2013). Alloreactive cytotoxic T cells provide means to decipher the immunopeptidome and reveal a plethora of tumor-associated self-epitopes. Proceedings of the National Academy of Sciences. 111(1). 403–408. 25 indexed citations
15.
Greve‐Isdahl, Margrethe, Nadia Mensali, Sébastien Wälchli, et al.. (2011). T cells raised against allogeneic HLA‐A2/CD20 kill primary follicular lymphoma and acute lymphoblastic leukemia cells. International Journal of Cancer. 130(8). 1821–1832. 7 indexed citations
16.
Strønen, Erlend, Gustav Gaudernack, Sébastien Wälchli, et al.. (2008). Dendritic Cells Engineered to Express Defined Allo‐HLA Peptide Complexes Induce Antigen‐specific Cytotoxic T Cells Efficiently Killing Tumour Cells. Scandinavian Journal of Immunology. 69(4). 319–328. 18 indexed citations
17.
Torgersen, Maria Lyngaas, Sébastien Wälchli, Stine Grimmer, Sigrid S. Skånland, & Kirsten Sandvig. (2007). Protein Kinase Cδ Is Activated by Shiga Toxin and Regulates Its Transport. Journal of Biological Chemistry. 282(22). 16317–16328. 48 indexed citations
18.
Lauvrak, Silje U., Sébastien Wälchli, Tore‐Geir Iversen, et al.. (2005). Shiga Toxin Regulates Its Entry in a Syk-dependent Manner. Molecular Biology of the Cell. 17(3). 1096–1109. 65 indexed citations
19.
Hetz, Claudio, Sébastien Wälchli, Sonia Carboni, et al.. (2005). The Disulfide Isomerase Grp58 Is a Protective Factor against Prion Neurotoxicity. Journal of Neuroscience. 25(11). 2793–2802. 173 indexed citations
20.
Huijsduijnen, Rob Hooft van, Sébastien Wälchli, Mark Ibberson, & Axel Harrenga. (2002). Protein tyrosine phosphatases as drug targets: PTP1B and beyond. Expert Opinion on Therapeutic Targets. 6(6). 637–647. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christina Voelkel‐Johnson Breakdown of academic impact, for papers by Chunqing Guo Breakdown of academic impact, for papers by Huijie Bian Breakdown of academic impact, for papers by Russell W. Jenkins Breakdown of academic impact, for papers by Thierry Dubois Breakdown of academic impact, for papers by Tomohiko Fukuda Breakdown of academic impact, for papers by Naoto Yamaguchi Breakdown of academic impact, for papers by Keith S. Hoek Breakdown of academic impact, for papers by Laura M. Selfors Breakdown of academic impact, for papers by Andrew C.G. Porter
Rankless by CCL
2026